BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31804362)

  • 1. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the prognostic value of long non-coding RNA AFAP1-AS1 for cancer patients in China.
    Liu RH; Wang MY; Chen LY; Yin ZJ; Ji QK; Wang YY; Jin BZ
    Oncotarget; 2018 Jan; 9(8):8100-8110. PubMed ID: 29487718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
    Zhou X; Fan YH; Wang Y; Wang F; Liu Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of long non-coding RNA ZEB1-AS1 as a prognostic biomarker in human solid tumors: A meta-analysis.
    Zuo XL; Cai J; Chen ZQ; Zhang Y; Liang LH; Wang JF; Wang JG; Wu J; Mao JD
    Clin Chim Acta; 2018 Oct; 485():14-20. PubMed ID: 29906419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
    Wu Y; Liu H; Shi X; Yao Y; Yang W; Song Y
    Oncotarget; 2015 Apr; 6(11):9160-72. PubMed ID: 25863539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PANDAR as a prognostic marker in Chinese cancer.
    Ma PJ; Guan QK; Xu DW; Zhao J; Qin N; Jin BZ
    Clin Chim Acta; 2017 Dec; 475():172-177. PubMed ID: 29066211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis.
    Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG
    Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis.
    Chen C; Feng Y; Wang X
    Clin Chim Acta; 2018 Sep; 484():265-271. PubMed ID: 29885321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA HOTTIP as an independent prognostic marker in cancer.
    Fan Y; Yan T; Chai Y; Jiang Y; Zhu X
    Clin Chim Acta; 2018 Jul; 482():224-230. PubMed ID: 28778381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA TUG1 as a potential prognostic biomarker in human cancers: a meta-analysis.
    Ma PJ; Guan QK; Meng L; Qin N; Zhao J; Jin BZ
    Oncotarget; 2017 Sep; 8(37):62454-62462. PubMed ID: 28977959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA HULC as a potential prognostic biomarker in human cancers: a meta-analysis.
    Fan YH; Wu MJ; Jiang Y; Ye M; Lu SG; Wu L; Zhu XG
    Oncotarget; 2017 Mar; 8(13):21410-21417. PubMed ID: 28199963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of long non-coding RNA HNF1A-AS1 in Chinese cancer patients: a meta-analysis.
    Zhuang C; Zheng L; Wang P
    Onco Targets Ther; 2018; 11():5325-5332. PubMed ID: 30214238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.